Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

STK33 Inhibitors

STK33 inhibitors constitute a notable chemical class that has attracted substantial scientific interest due to their intricate mechanism of action and implications in cellular dynamics. These inhibitors are meticulously designed molecules aimed at selectively modulating the activity of serine/threonine kinase 33 (STK33), a pivotal enzyme with intricate involvement in various essential cellular processes. STK33, as a kinase, plays a central role in signal transduction pathways that regulate critical cellular functions like proliferation, differentiation, apoptosis, and metabolism. The chemical structure of STK33 inhibitors is carefully engineered to complement the three-dimensional arrangement of the enzyme's active site. This allows these inhibitors to bind with high specificity and affinity to STK33, effectively obstructing its catalytic function. The inhibition transpires through a series of non-covalent interactions, including hydrogen bonding, electrostatic interactions, and hydrophobic contacts.

These interactions collectively perturb the enzyme's active conformation, impeding its ability to phosphorylate target substrates. By inhibiting STK33, these molecules can lead to intricate downstream effects within cellular signaling networks. The disruption of STK33-mediated phosphorylation cascades can influence the activation or deactivation of key proteins involved in diverse cellular pathways. Consequently, these inhibitors can indirectly impact processes such as gene expression, cell cycle progression, and cytoskeletal rearrangement. Researchers have been intently exploring the applications of STK33 inhibitors in the context of deciphering cellular complexities and unraveling disease mechanisms. Their precise mode of action offers a unique tool for probing intricate cellular processes that hinge upon kinase-mediated signaling events. By employing STK33 inhibitors, scientists can dissect the contribution of this kinase in both normal and pathological conditions, shedding light on the intricate web of molecular interactions that govern cell behavior.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that broadly targets various kinases and could potentially impact STK33 activity through non-specific kinase inhibition.

PI-103

371935-74-9sc-203193
sc-203193A
1 mg
5 mg
$33.00
$131.00
3
(1)

A dual PI3K/mTOR inhibitor that might affect STK33 by altering the signaling environment that supports cell survival and proliferation.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Targets multiple kinases involved in cell proliferation and survival, potentially affecting STK33′s functional role indirectly.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An MEK inhibitor, which could alter cellular signaling cascades that interact with or influence STK33′s regulatory functions.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

A broad-spectrum tyrosine kinase inhibitor that might have off-target effects impacting STK33′s activity in signal transduction.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

A Src family kinase inhibitor that could alter signaling networks, potentially affecting pathways where STK33 is active.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which could modify cellular responses in stress signaling pathways potentially linked to STK33.

AZD2014

1009298-59-2sc-364420
5 mg
$303.00
2
(0)

An mTOR inhibitor that might disrupt cellular processes influencing STK33′s role in cell growth and survival.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

An EGFR tyrosine kinase inhibitor that could impact signaling pathways potentially associated with STK33 activity.